These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35899950)

  • 1. Role of Fine Silica as Amorphous Solid Dispersion Carriers for Enhancing Drug Load and Preventing Recrystallization- A Comprehensive Review.
    Trivedi R; Chatterjee B; Kalave S; Pandya M
    Curr Drug Deliv; 2023; 20(6):694-707. PubMed ID: 35899950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
    Baumgartner A; Planinšek O
    Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies.
    Budiman A; Anastasya G; Handini AL; Lestari IN; Subra L; Aulifa DL
    Int J Nanomedicine; 2024; 19():2199-2225. PubMed ID: 38465205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High loading of lipophilic compounds in mesoporous silica for improved solubility and dissolution performance.
    Benedikt Brenner M; Wüst M; Kuentz M; Wagner KG
    Int J Pharm; 2024 Apr; 654():123946. PubMed ID: 38417728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide.
    Mura P; Valleri M; Fabianelli E; Maestrelli F; Cirri M
    Int J Pharm; 2019 May; 563():43-52. PubMed ID: 30926527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation strategies for the development of high drug-loaded amorphous solid dispersions.
    Mamidi H; Palekar S; Patel H; Nukala PK; Patel K
    Drug Discov Today; 2023 Dec; 28(12):103806. PubMed ID: 37890714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compared with colloidal silica and porous silica as baicalin solid dispersion carrier].
    Yan HM; Ding DM; Wang J; Sun E; Jia XB; Zhang ZH
    Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2484-8. PubMed ID: 25276968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug.
    Li J; Xu L; Yang B; Wang H; Bao Z; Pan W; Li S
    Int J Pharm; 2015 Aug; 492(1-2):191-8. PubMed ID: 26163764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.